U.S. NRC Dockets Terra Innovatum’s SOLO™ Micro-Modular Reactor Topical Reports, Initiating the Formal Review and Approval Process

Rhea-AI Summary

Terra Innovatum (NASDAQ:NKLR) announced that the U.S. Nuclear Regulatory Commission has docketed several key topical reports for the SOLO™ Micro-Modular Reactor, initiating the NRC's formal technical review.

The docketed reports cover principal design criteria, quality assurance, safeguards/MC&A, and nuclear design, with NRC Safety Evaluations anticipated by October 2026. The company targets first-of-a-kind deployment in 2027 and initial commercial fleet deployment in 2028.

Positive

• NRC docketing of key topical reports initiating formal technical review
• NRC Safety Evaluations expected by October 2026
• Dual-licensing strategy advancing Construction Permit and Operating License in parallel
• FOAK design identical to commercial units to streamline commercialization
• Targeted FOAK deployment 2027 and commercial deployment 2028

Negative

• No regulatory approvals yet; Construction Permit and operating authorization remain targeted for 2027

News Market Reaction – NKLR

-1.13%

15 alerts

-1.13% News Effect

+4.3% Peak Tracked

-13.3% Trough Tracked

-$4M Valuation Impact

$310M Market Cap

0.7x Rel. Volume

On the day this news was published, NKLR declined 1.13%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.3% during that session. Argus tracked a trough of -13.3% from its starting point during tracking. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $310M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Safety Evaluation target: October 2026 Technical review year: 2026 Safety Evaluations timing: Late 2026 +2 more

5 metrics

Safety Evaluation target October 2026 Anticipated NRC Safety Evaluation completion of SOLO topical reports

Technical review year 2026 NRC technical review of SOLO topical reports

Safety Evaluations timing Late 2026 NRC Safety Evaluations of the set of Topical Reports expected

FOAK authorization target 2027 Targeted Construction Permit and first-of-a-kind operating authorization

Commercial fleet target 2028 Targeted initial commercial fleet deployment

Market Reality Check

Price: $4.08 Vol: Volume 241,508 is below t...

low vol

$4.08 Last Close

Volume Volume 241,508 is below the 20-day average of 447,195 (relative volume 0.54x). low

Technical Shares at 4.41 are trading below the 200-day MA of 6.2 and 79.87% under the 52-week high.

Peers on Argus

No peer stocks in the provided sector list showed momentum flags, indicating tod...

No peer stocks in the provided sector list showed momentum flags, indicating today’s move in NKLR appears stock-specific rather than part of a broader sector rotation.

Historical Context

5 past events · Latest: Feb 09 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 09	Supply-chain readiness	Positive	+3.4%	Secured full end-to-end supply chain components for SOLO reactor deployment.
Feb 02	Licensing milestone	Positive	-7.8%	Completed PIRT milestone supporting U.S. licensing and NRC submissions.
Jan 26	Conference participation	Positive	-7.6%	Planned investor and industry conference updates on regulatory and commercialization plans.
Dec 18	Award & funding	Positive	+1.3%	Received UNCA sustainability mention and highlighted funding and commercialization targets.
Dec 17	NRC engagement	Positive	-8.8%	Reported expanded NRC submissions and frequent regulatory engagement for SOLO licensing.

Pattern Detected

Recent positive regulatory and commercialization updates often saw mixed or negative next-day price reactions, suggesting a tendency for the stock to sell off on good news.

Recent Company History

Over the last few months, Terra Innovatum has steadily advanced SOLO™ toward commercialization. In Dec 2025, expanded NRC submissions and a sustainability award drew modestly mixed price moves, while a Feb 9, 2026 supply-chain readiness update aligned with a 3.37% gain. Other positive licensing and investor-relations milestones on Feb 2 and Jan 26 coincided with declines, underscoring a pattern where constructive regulatory progress does not always translate into immediate share strength.

Market Pulse Summary

This announcement detailed a key regulatory step as the NRC docketed SOLO™ topical reports, formally...

Analysis

This announcement detailed a key regulatory step as the NRC docketed SOLO™ topical reports, formally starting technical review toward anticipated Safety Evaluations by October 2026 and targeted deployment in 2027–2028. It builds on prior licensing and supply-chain milestones. Investors may track future NRC evaluations, progress on construction permit and operating authorizations, funding disclosures, and any updates that could affect the projected commercialization schedule for the SOLO™ micro‑modular reactor.

Key Terms

nuclear regulatory commission, construction permit, operating license, safety evaluation, +4 more

8 terms

nuclear regulatory commission regulatory

"the U.S. Nuclear Regulatory Commission (NRC) has formally docketed several key topical"

The Nuclear Regulatory Commission is a government agency responsible for overseeing the safety and security of nuclear power plants and radioactive materials. It sets rules and monitors practices to prevent accidents and protect public health. For investors, its regulations can influence the stability and operation costs of nuclear energy companies, affecting their long-term viability.

construction permit regulatory

"preparation of the Construction Permit Application for the first-of-a-kind deployment"

A construction permit is an official authorization from a local or national government allowing a project to build, alter, or occupy a structure according to approved plans and safety rules. For investors it signals that a project has cleared key regulatory and safety checks and can proceed on schedule, affecting timelines, costs and revenue prospects — think of it as a green light that reduces uncertainty and helps estimate when an asset will start producing value.

operating license regulatory

"as part of the Construction Permit and Operating License Application"

An operating license is an official permit from a government or regulatory body that allows a company to carry out specific business activities, such as selling products, running a facility, or providing services. For investors it matters because the license is often required for a company to earn revenue; losing, not obtaining, or facing restrictions on the license can stop operations or add costs, much like a business losing its driver’s license would be unable to legally drive its core activity.

safety evaluation regulatory

"The review will culminate in the preparation of NRC Safety Evaluations (SEs) for each"

A safety evaluation is the process of assessing whether a product, drug, procedure, or operation poses acceptable risks to people, typically through testing, monitoring, and review of harmful side effects or incidents. For investors, it matters because a positive safety evaluation helps secure regulatory approval and wider market access, while safety concerns can delay product launches, prompt recalls, or create legal and reputational costs—similar to how a vehicle crash-test report affects consumer and regulator trust.

topical reports regulatory

"has formally docketed several key topical reports supporting the licensing of the SOLO"

Topical reports are focused briefings that examine a single issue, trend, or event—such as a regulatory change, industry development, or market theme—and explain its likely effects on companies and investors. They matter because they turn complex information into clear, actionable insight, helping investors weigh risks and opportunities quickly, much like a targeted weather report that forecasts how one storm will affect travel plans.

quality assurance plan technical

"SOLO Project Quality Assurance PlanSOLO Safeguards Methodology and Implementation"

A quality assurance plan is a documented set of procedures, tests and oversight steps designed to ensure a product, process or service consistently meets regulatory and internal standards. For investors it shows how a company prevents defects, compliance failures and costly recalls; like a detailed home-inspection checklist, a strong plan reduces surprises, supports reliable production and helps protect revenue and reputation.

material control & accountancy (mc&a) regulatory

"Safeguards Methodology and Implementation of Material Control & Accountancy (MC&A)"

Material control and accountancy (MC&A) is a system that tracks, records and secures important or regulated physical materials—such as chemicals, pharmaceuticals or nuclear substances—throughout their lifecycle, like an inventory plus security log for valuable items. Investors care because strong MC&A reduces the risk of loss, theft, regulatory fines or operational shutdowns, and signals that a company manages regulatory and safety risks that could affect earnings and reputation.

micro-modular reactor technical

"developer of the SOLO™ Micro-Modular Reactor, today announced that the U.S."

A micro-modular reactor is a very small, factory-built nuclear power unit designed to produce a modest amount of steady electricity or heat and to be combined with others as needed, like Lego blocks for a power plant. For investors it matters because these units promise lower individual upfront costs, faster factory production and flexible scaling, while also carrying regulatory, long-term construction and public-acceptance risks that affect returns.

AI-generated analysis. Not financial advice.

• Major regulatory milestone advancing SOLO™ achieved with the submittal of key Topical Reports in preparation of the Construction Permit Application for the first-of-a-kind deployment
• NRC determines key licensing submissions contain sufficient information to begin formal safety review
• Technical evaluation now underway as part of the reactor’s licensing pathway
• [Completion of] NRC Safety Evaluation of the Topical Reports anticipated by October 2026

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR), developer of the SOLO™ Micro-Modular Reactor, today announced that the U.S. Nuclear Regulatory Commission (NRC) has formally docketed several key topical reports supporting the licensing of the SOLO™ reactor design.

Docketing represents an important regulatory milestone in the U.S. nuclear licensing process and it means that the NRC has determined that Terra Innovatum’s submissions contain sufficient technical information to begin detailed safety and design evaluation as part of the Construction Permit and Operating License Application.

With the docketing of these reports, the SOLO™ Micro-Modular Reactor has formally entered the NRC’s technical review process, advancing the company’s regulatory pathway toward approval to construct and operate its first reactor.

“We believe the docketing of these reports reflects the technical preparation and maturity of the SOLO program,” said Alessandro Petruzzi, Co-Founder and Chief Executive Officer of Terra Innovatum. “Entering the NRC’s formal technical review process represents one of the most significant regulatory milestones in the nuclear licensing pathway and supports our goal of first-of-a-kind deployment.”

“Docketing initiates the NRC’s detailed evaluation of key design, safety, and regulatory elements,” said Cesare Frepoli, Co-Founder, Chief Operating Officer and Director of Regulatory Affairs for Terra Innovatum. “Our team is actively supporting the NRC audit process as we work toward safety evaluation of the Topical Reports and continued progress toward licensing.”

The docketed submissions include:

• SOLO Nuclear Reactor Principal Design Criteria
• SOLO Project Quality Assurance Plan
• SOLO Safeguards Methodology and Implementation of Material Control & Accountancy (MC&A)
• SOLO Nuclear Design

Together, these reports outline the fundamental engineering, safety, and regulatory framework for the SOLO™ reactor and support the broader licensing pathway required for reactor construction and operation.

Following docketing, the NRC has initiated its technical audit phase — a standard component of the agency’s review process that allows regulators to examine supporting analyses, methodologies, and design implementation in detail.

The review will culminate in the preparation of NRC Safety Evaluations (SEs) for each topical area. Safety Evaluation determinations are currently anticipated by October 2026.

Completion of these reviews would represent a major regulatory milestone supporting Terra Innovatum’s targeted timeline for first-of-a-kind deployment of the SOLO™ reactor in 2027 and broader commercial deployment beginning in 2028.

The SOLO™ Micro-Modular Reactor is designed to deliver scalable, carbon-free baseload power for energy-intensive infrastructure including industrial facilities, data centers, and remote energy systems. As global electricity demand accelerates, particularly from digital infrastructure and industrial electrification, micro-modular nuclear technologies are increasingly being evaluated as reliable long-term clean energy solutions.

Regulatory Licensing Pathway

Terra Innovatum is pursuing a dual-licensing strategy with the U.S. Nuclear Regulatory Commission (NRC), advancing both Construction Permit and Operating License pathways for the SOLO™ Micro-Modular Reactor in parallel.

This approach is enabled by the company’s decision to deploy the same reactor design for its first-of-a-kind (FOAK) unit and its future commercial fleet. Unlike many advanced reactor programs that build prototype systems which evolve between demonstration and commercialization, Terra Innovatum’s FOAK SOLO™ reactor is designed to be identical to the commercial units intended for fleet deployment.

As a result, key elements of the reactor design, safety systems, and regulatory framework are being reviewed with commercialization in mind from the outset.

By advancing the Construction Permit and Operating License pathways concurrently, Terra Innovatum aims to streamline regulatory review and reduce the time required to transition from first deployment to broader commercial rollout.

The NRC’s docketing of the SOLO™ topical reports marks the beginning of formal technical evaluation of the design elements supporting this licensing strategy.

SOLO™ Reactor Estimated Regulatory Timeline

Terra Innovatum’s licensing program is progressing through several key regulatory milestones:

2026 — NRC technical review of SOLO™ topical reports
Late 2026 — NRC Safety Evaluations (SEs) of the set of Topical Reports expected
2027 — Targeted Construction Permit and first-of-a-kind operating authorization
2028 — Targeted initial commercial fleet deployment

Completion of these milestones would position Terra Innovatum among the first companies advancing next-generation micro-modular nuclear reactor technology toward commercial deployment.

ABOUT TERRA INNOVATUM & SOLO^TM

Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time.

Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.

It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.

SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.

To learn more, visit: https://investors.terrainnovatum.com/. Follow us on X: https://x.com/TerraInnovatum and LinkedIn: https://www.linkedin.com/company/terra-innovatum-solo/.

FORWARD LOOKING STATEMENTS

This press release includes “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, opinions and projections prepared by Terra Innovatum’s management. Forward-looking statements generally relate to future events or future financial or operating performance, including pro forma and estimated financial information, and other “forward-looking statements” (as such term is defined in the Private Securities Litigation Reform Act of 1995). For example, projections of future sales, EBITDA, Adjusted EBITDA and other metrics are forward-looking statements. The recipient can identify forward-looking statements because they typically contain words such as “outlook,” “believes,” “expects,” “ will,” “projected,” “continue,” “increase,” “may,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negatives or variations of these words or other comparable words and/or similar expressions (but the absence of these words and/or similar expressions does not mean that a statement is not forward-looking). These forward-looking statements specifically include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share and the potential success of Terra Innovatum’s strategy and expectations. Forward-looking statements, opinions and projections are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of Terra Innovatum’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Terra Innovatum’s control. These uncertainties and risks may be known or unknown. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: changes in domestic and foreign business, market, financial, political and legal conditions; changes in timing of expected regulatory review process; failure to realize the anticipated benefits of the proposed business combination; risks relating to the uncertainty of the projected financial information with respect to Terra Innovatum; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; Terra Innovatum’s ability to manage future growth; Terra Innovatum’s ability to develop new products and services, bring them to market in a timely manner, and make enhancements to its platform; the effects of competition on Terra Innovatum’s future business; and the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries. If any of these risks materialize or the Terra Innovatum’s assumptions prove incorrect, actual results could differ materially from the results implied by the forward-looking statements contained herein. In addition, forward-looking statements reflect Terra Innovatum’s expectations and views as of the date of this presentation. Terra Innovatum anticipates that subsequent events and developments will cause its assessments to change. However, while Terra Innovatum may elect to update these forward-looking statements in the future, each of them specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on the forward-looking statements, which speak only as of the date they are made.

CONTACTS

Giordano Morichi
Founding Partner, Chief Business Development Officer & Investor Relations
Terra Innovatum Global N.V.
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com

Kaitlin Taylor
Vice President
Investor Relations
Alliance Advisors IR
E: investors@terrainnovatum.com

Fatema Bhabrawala
Director
Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com

FAQ

What did Terra Innovatum (NKLR) file with the NRC on March 5, 2026?

The company had key topical reports docketed by the NRC to begin formal technical review. According to Terra Innovatum, the docketed reports include design criteria, quality assurance, safeguards/MC&A, and nuclear design supporting the SOLO™ licensing pathway.

When does Terra Innovatum expect NRC Safety Evaluations for SOLO™ (NKLR)?

Safety Evaluations are anticipated by October 2026, per the company's timeline. According to Terra Innovatum, the NRC's technical audit phase is underway and will culminate in Safety Evaluation determinations for each topical area.

How does the NKLR dual-licensing strategy affect SOLO™ deployment timing?

Terra Innovatum is pursuing parallel Construction Permit and Operating License reviews to streamline approval timing. According to the company, this approach uses an identical FOAK-to-commercial design to reduce transition time from first deployment to fleet rollout.

What are Terra Innovatum's target dates for SOLO™ deployment (NKLR)?

The company targets first-of-a-kind deployment in 2027 and initial commercial fleet deployment in 2028. According to Terra Innovatum, completion of NRC Safety Evaluations by October 2026 supports these targeted milestones.

Which technical topical reports were docketed by the NRC for SOLO™ (NKLR)?

Docketed submissions include principal design criteria, project quality assurance, safeguards/MC&A methodology, and nuclear design. According to Terra Innovatum, these reports outline engineering, safety, and regulatory frameworks for the SOLO™ reactor.

What does NRC docketing mean for NKLR investors and the SOLO™ program?

Docketing means the NRC found the submissions sufficiently complete to start detailed safety review. According to Terra Innovatum, this milestone formally begins the agency's technical audit and moves the program closer to potential construction and operation authorization.